PineBridge Investments’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,404
| Closed | -$833K | – | 560 |
|
|
2026
Q1 | $833K | Sell |
1,404
-2,583
| -65% | -$1.29M | 0.01% | 396 |
|
|
2025
Q4 | $1.94M | Sell |
3,987
-7,327
| -65% | -$3.41M | 0.01% | 346 |
|
|
2025
Q3 | $4.74M | Sell |
11,314
-6,837
| -38% | -$2.3M | 0.04% | 288 |
|
|
2025
Q2 | $5.22M | Buy |
18,151
+7,914
| +77% | +$2.37M | 0.04% | 309 |
|
|
2025
Q1 | $3.16M | Sell |
10,237
-22,752
| -69% | -$7.8M | 0.03% | 376 |
|
|
2024
Q4 | $11.6M | Buy |
32,989
+7,558
| +30% | +$2.78M | 0.09% | 199 |
|
|
2024
Q3 | $9.11M | Buy |
25,431
+23,745
| +1,408% | +$8.02M | 0.07% | 234 |
|
|
2024
Q2 | $537K | Buy |
+1,686
| New | +$446K | ﹤0.01% | 478 |
|
|
2023
Q4 | – | Sell |
-7,329
| Closed | -$1.66M | – | 675 |
|
|
2023
Q3 | $1.66M | Sell |
7,329
-597
| -8% | -$138K | 0.02% | 383 |
|
|
2023
Q2 | $1.75M | Buy |
7,926
+77
| +1% | +$17.1K | 0.02% | 377 |
|
|
2023
Q1 | $1.76M | Sell |
7,849
-118
| -1% | -$29.1K | 0.02% | 365 |
|
|
2022
Q4 | $2.22M | Buy |
7,967
+1,808
| +29% | +$456K | 0.03% | 345 |
|
|
2022
Q3 | $1.29M | Buy |
6,159
+65
| +1% | +$14.5K | 0.02% | 369 |
|
|
2022
Q2 | $1.44M | Buy |
+6,094
| New | +$1.24M | 0.02% | 374 |
|
|
2020
Q4 | – | Sell |
-38
| Closed | -$4K | – | 703 |
|
|
2020
Q3 | $4K | Buy |
+38
| New | +$4.17K | ﹤0.01% | 641 |
|
|
2018
Q1 | – | Sell |
-88
| Closed | -$13K | – | 1170 |
|
|
2017
Q4 | $13K | Buy |
88
+8
| +10% | +$1.02K | ﹤0.01% | 1008 |
|
|
2017
Q3 | $9K | Buy |
+80
| New | +$10.2K | ﹤0.01% | 1140 |
|
|
2017
Q2 | – | Sell |
-987
| Closed | -$134K | – | 1186 |
|
|
2017
Q1 | $134K | Sell |
987
-53
| -5% | -$8.03K | ﹤0.01% | 870 |
|
|
2016
Q4 | $149K | Sell |
1,040
-53,471
| -98% | -$6.83M | ﹤0.01% | 899 |
|
|
2016
Q3 | $6.44M | Buy |
54,511
+51,486
| +1,702% | +$6.19M | 0.29% | 115 |
|
|
2016
Q2 | $320K | Buy |
3,025
+362
| +14% | +$40.4K | 0.02% | 358 |
|
|
2016
Q1 | $297K | Sell |
2,663
-10,195
| -79% | -$1.29M | 0.02% | 365 |
|
|
2015
Q4 | $2.01M | Buy |
12,858
+4,425
| +52% | +$644K | 0.09% | 187 |
|
|
2015
Q3 | $1.11M | Buy |
+8,433
| New | +$1.35M | 0.05% | 235 |
|
|
2014
Q4 | – | Sell |
-1,638
| Closed | -$211K | – | 1150 |
|
|
2014
Q3 | $211K | Sell |
1,638
-30,618
| -95% | -$3.16M | 0.01% | 633 |
|
|
2014
Q2 | $2.85M | Buy |
32,256
+22,728
| +239% | +$2.19M | 0.11% | 185 |
|
|
2014
Q1 | $896K | Buy |
9,528
+774
| +9% | +$79.2K | 0.03% | 304 |
|
|
2013
Q4 | $990K | Sell |
8,754
-59,184
| -87% | -$5.34M | 0.03% | 317 |
|
|
2013
Q3 | $5.36M | Buy |
67,938
+6,928
| +11% | +$506K | 0.17% | 152 |
|
|
2013
Q2 | $4.02M | Buy |
+61,010
| New | +$3.93M | 0.13% | 175 |
|
Other funds holding UTHR
ACA
JT
PineBridge Investments's UTHR Position: Q2 2026 in Review
PineBridge Investments sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 1,404 shares — an estimated $833K sold.
PineBridge Investments first reported a position in UTHR in Q2 2013 and held it in 30 quarters. The position peaked at $11.6M in Q4 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- PineBridge Investments reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
- PineBridge Investments sold 1,404 United Therapeutics shares in Q2 2026, an estimated $833K.
- PineBridge Investments first reported a position in United Therapeutics in Q2 2013 and held it in 30 quarters.
- PineBridge Investments's United Therapeutics position peaked at $11.6M in Q4 2024.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.